» Articles » PMID: 35528229

Dissecting Central Post-stroke Pain: a Controlled Symptom-psychophysical Characterization

Abstract

Central post-stroke pain affects up to 12% of stroke survivors and is notoriously refractory to treatment. However, stroke patients often suffer from other types of pain of non-neuropathic nature (musculoskeletal, inflammatory, complex regional) and no head-to-head comparison of their respective clinical and somatosensory profiles has been performed so far. We compared 39 patients with definite central neuropathic post-stroke pain with two matched control groups: 32 patients with exclusively non-neuropathic pain developed after stroke and 31 stroke patients not complaining of pain. Patients underwent deep phenotyping via a comprehensive assessment including clinical exam, questionnaires and quantitative sensory testing to dissect central post-stroke pain from chronic pain in general and stroke. While central post-stroke pain was mostly located in the face and limbs, non-neuropathic pain was predominantly axial and located in neck, shoulders and knees ( < 0.05). Neuropathic Pain Symptom Inventory clusters burning (82.1%,  = 32,  < 0.001), tingling (66.7%,  = 26,  < 0.001) and evoked by cold (64.1%,  = 25,  < 0.001) occurred more frequently in central post-stroke pain. Hyperpathia, thermal and mechanical allodynia also occurred more commonly in this group ( < 0.001), which also presented higher levels of deafferentation ( < 0.012) with more asymmetric cold and warm detection thresholds compared with controls. In particular, cold hypoesthesia (considered when the threshold of the affected side was <41% of the contralateral threshold) odds ratio (OR) was 12 (95% CI: 3.8-41.6) for neuropathic pain. Additionally, cold detection threshold/warm detection threshold ratio correlated with the presence of neuropathic pain ( = -0.4,  < 0.001). Correlations were found between specific neuropathic pain symptom clusters and quantitative sensory testing: paroxysmal pain with cold ( = -0.4;  = 0.008) and heat pain thresholds ( = 0.5;  = 0.003), burning pain with mechanical detection ( = -0.4;  = 0.015) and mechanical pain thresholds ( = -0.4,  < 0.013), evoked pain with mechanical pain threshold ( = -0.3;  = 0.047). Logistic regression showed that the combination of cold hypoesthesia on quantitative sensory testing, the Neuropathic Pain Symptom Inventory, and the allodynia intensity on bedside examination explained 77% of the occurrence of neuropathic pain. These findings provide insights into the clinical-psychophysics relationships in central post-stroke pain and may assist more precise distinction of neuropathic from non-neuropathic post-stroke pain in clinical practice and in future trials.

Citing Articles

Neuroimage Signature in Post-Stroke Pain: A Systematic Review.

Buzhanskyy A, Duarte I, Patto A, Donato H, Castelo-Branco M, Abejas A Curr Pain Headache Rep. 2025; 29(1):43.

PMID: 39885090 DOI: 10.1007/s11916-024-01339-y.


Prediction of Central Post-Stroke Pain by Quantitative Sensory Testing.

Asseyer S, Panagoulas E, Maidhof J, Villringer K, Al E, Chen X Ann Neurol. 2024; 97(3):507-520.

PMID: 39727056 PMC: 11831871. DOI: 10.1002/ana.27138.


Contributions of neuroimaging in central poststroke pain: a review.

Lemos M, Barbosa L, Ciampi de Andrade D, Lucato L Arq Neuropsiquiatr. 2024; 82(9):1-11.

PMID: 39216489 PMC: 11500300. DOI: 10.1055/s-0044-1789225.


Feedback Interventions in Motor Recovery of Lateropulsion after Stroke: A Literature Review and Case Series.

Gomez-Risquet M, Hochsprung A, Magni E, Luque-Moreno C Brain Sci. 2024; 14(7).

PMID: 39061422 PMC: 11275014. DOI: 10.3390/brainsci14070682.


Role of Brain Derived Neurotrophic Factor and Related Therapeutic Strategies in Central Post-Stroke Pain.

Rajamanickam G, Lee A, Liao P Neurochem Res. 2024; 49(9):2303-2318.

PMID: 38856889 DOI: 10.1007/s11064-024-04175-z.


References
1.
Truini A, Padua L, Biasiotta A, Caliandro P, Pazzaglia C, Galeotti F . Differential involvement of A-delta and A-beta fibres in neuropathic pain related to carpal tunnel syndrome. Pain. 2009; 145(1-2):105-9. DOI: 10.1016/j.pain.2009.05.023. View

2.
Sommer C, Richter H, Rogausch J, Frettloh J, Lungenhausen M, Maier C . A modified score to identify and discriminate neuropathic pain: a study on the German version of the Neuropathic Pain Symptom Inventory (NPSI). BMC Neurol. 2011; 11:104. PMC: 3180265. DOI: 10.1186/1471-2377-11-104. View

3.
Demant D, Lund K, Vollert J, Maier C, Segerdahl M, Finnerup N . The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study. Pain. 2014; 155(11):2263-73. DOI: 10.1016/j.pain.2014.08.014. View

4.
Ciampi de Andrade D, Teixeira M, Galhardoni R, Ferreira K, Braz Mileno P, Scisci N . Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind Trial. Oncologist. 2017; 22(10):1154-e105. PMC: 5634769. DOI: 10.1634/theoncologist.2017-0235. View

5.
Valerio F, Apostolos-Pereira S, Sato D, Callegaro D, Lucato L, Barboza V . Characterization of pain syndromes in patients with neuromyelitis optica. Eur J Pain. 2020; 24(8):1548-1568. DOI: 10.1002/ejp.1608. View